Home Influence of amide versus ester linkages on the anticancer properties of the new flavone–biotin conjugates
Article
Licensed
Unlicensed Requires Authentication

Influence of amide versus ester linkages on the anticancer properties of the new flavone–biotin conjugates

  • Monika Stompor EMAIL logo , Marta Świtalska , Agata Bajek and Joanna Wietrzyk
Published/Copyright: May 17, 2019
Become an author with De Gruyter Brill

Abstract

Novel biotinylated C-6 substituted flavones were synthesised by a one-step method that connects biotin to 6-hydroxyflavone and 6-aminoflavone by esterification and amidation of hydroxyl and amino groups, respectively. The obtained compounds, 6-O-biotinylflavone and 6-biotinylamidoflavone, are the bifunctional molecules composed of a flavone moiety as a fluorescent reporter and biotin as a cancer-targeting unit. Antiproliferative activity was evaluated using SRB assays in MCF-7, MCF-10A, HepG2, MDA-MB-231, 4T1, and Balb/3T3 cell lines. In vitro evaluation revealed that compounds with biotin moiety displayed better cell selectivity between the cancer and normal cells than the parental substrates. These results indicate that anticancer effect is not related to the position of biotin moiety, but it is related to the presence of ester or amide bond. 6-O-Biotinylflavone was more active than 6-hydroxyflavone against human breast (MDA-MB-231) and liver (HepG2) cancer cells with IC50 (concentration of tested agent that inhibits proliferation of the cell population by 50%) values equal to 78.5 ± 18.8 μM and 133.2 ± 14.2 μM, respectively. Non biotinylated 6-aminoflavone was more active than 6-biotinylamidoflavone against all tested cell lines, with IC50 values between 34.3 ± 9.1 μM (4T1) and 173.86 ± 24.3 μM (MCF-7).

Funding source: National Science Centre, Poland

Award Identifier / Grant number: 2017/01/X/NZ9/00161

Funding statement: This study was financed by grant no. 2017/01/X/NZ9/00161 assigned by the National Science Centre, Poland, to M. Stompor.

  1. Author contributions: M. Stompor conceived the research, designed the experiment, performed the synthetic part of the experimental work, analysed the data, and wrote the manuscript. M. Świtalska performed the biological assays. A.B. measured the NMR spectra. J.W. supervised the biological assays.

  2. Conflict of interest: The authors declare that they have no competing interests.

References

1. Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, et al. Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin Cancer Biol 2015;35:25–54.10.1016/j.semcancer.2015.02.006Search in Google Scholar PubMed PubMed Central

2. Aslam MS, Naveed S, Ahmed A, Abbas Z, Gull I, Athar MA. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J Cancer Ther 2014;5:817–22.10.4236/jct.2014.58089Search in Google Scholar

3. Waks AG, Winer EP. Breast cancer treatment: a review. J Am Med Assoc 2019;321:288–300.10.1001/jama.2018.19323Search in Google Scholar PubMed

4. Lebert JM, Lester MD, Powell MD, Seal M, McCarthy MD. Advances in the systemic treatment of triple-negative breast cancer. Curr Oncol 2018;25:142–50.10.3747/co.25.3954Search in Google Scholar PubMed PubMed Central

5. Teekaraman D, Elayapillai SP, Viswanathan MP, Jagadeesan A. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line. Chem Biol Interact 2019;300:91–100.10.1016/j.cbi.2019.01.008Search in Google Scholar PubMed

6. Kaur G, Verma N. Nature curing cancer – review on structural modification studies with natural active compounds having anti-tumor efficiency. Biotechnol Rep 2015;6:64–78.10.1016/j.btre.2015.01.005Search in Google Scholar PubMed PubMed Central

7. Nagaprashantha LD, Singhal J, Chikara S, Gugiu G, Horne D, Awasthi S, et al. 2′-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells. J Proteom 2019;192:233–45.10.1016/j.jprot.2018.09.005Search in Google Scholar PubMed PubMed Central

8. Ren L, Wang F, Xu Z, Chan WM, Zhao C, Xue H. GABAA receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone. Biochem Pharmacol 2010;79:1337–44.10.1016/j.bcp.2009.12.024Search in Google Scholar PubMed

9. Hirano T, Oka K, Akiba M. Antiproliferative effects on synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol 1989;64:69–78.Search in Google Scholar PubMed

10. Chang H, Mi MT, Gu YY, Yuan JL, Ling WH, Lin H. Effects of flavonoids with different structures on proliferation of leukemia cell line HL-60. Ai Zheng 2007;26:1309–14.Search in Google Scholar PubMed

11. Lee JH, Regmi SC, Kim JA, Cho MH, Yun H, Lee CS, et al. Apple flavonoids phloretin inhibits Escherichia coli O157:H7 biofilm formation and ameliorates colon inflammation in rats. Infect Immun 2011;79:4819–27.10.1128/IAI.05580-11Search in Google Scholar PubMed PubMed Central

12. Lai CH, Wu YW, Yeh SD, Lin YH, Tsai YH. Effects of 6-hydroxyflavone on osteoblast differentiation in MC3T3-E1 cells. J Evid Based Complement Altern Med 2014;14:ID 924560.10.1155/2014/924560Search in Google Scholar PubMed PubMed Central

13. Wang X, Wang Z, Sidhu PS, Desai UR, Zhou Q. 6-Hydroxyflavone and derivatives exhibit potent anti-inflammatory activity among mono-, di- and polyhydroxylated flavones in kidney mesangial cells. PLoS One 2015;10:e0116409.10.1371/journal.pone.0116409Search in Google Scholar PubMed

14. Ohno S, Shinoda S, Toyoshima S, Nakazawa H, Makino T, Nakajin S. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. J Steroid Biochem Mol Biol 2002;80:355–63.10.1016/S0960-0760(02)00021-3Search in Google Scholar PubMed

15. Stompor M, Dancewicz K, Gabryś B, Anioł M. Insect antifeedant potential of xanthohumol and isoxanthohumol and their derivatives. J Agric Food Chem 2015;63:6749–56.10.1021/acs.jafc.5b02025Search in Google Scholar PubMed

16. Wanich S, Yenjai C. Amino and nitro derivatives of 5,7-dimethoxyflavone from Kaempferia parviflora and cytotoxicity against KB cell line. Arch Pharm Res 2009;32:1185–9.10.1007/s12272-009-1901-ySearch in Google Scholar PubMed

17. Santos MB, Pinhanelli VC, Garcia MAR, Silva G, Baek SJ, França SC, et al. Antiproliferative and pro-apoptotic activities of 2′- and 4′-aminochalcones against tumor canine cells. Eur J Med Chem 2017;138:884–9.10.1016/j.ejmech.2017.06.049Search in Google Scholar PubMed

18. Simon L, Srinivasan KK, Rao CM, Kumar N, Reddy N, Biswas S, et al. Synthesis and evaluation of anticancer activity of some 6-aminoflavones. Int J Pharm Chem 2015;5:240–6.Search in Google Scholar

19. Zempleni J, Mock D. Biotin biochemistry and human requirements. J Nutr Biochem 1999;10:128–38.10.1016/S0955-2863(98)00095-3Search in Google Scholar PubMed

20. Agrwal S, Agrwal A, Said HM. Biotin deficiency enhances the inflammatory response of human dendritic cells. Am J Physiol Cell Physiol 2016;311:386–91.10.1152/ajpcell.00141.2016Search in Google Scholar PubMed PubMed Central

21. Sugita Y, Shirakawa H, Sugimoto R, Furukawa Y, Komai M. Effect of biotin treatment on hepatic gene expression in streptozotocin-induces diabetic rats. Biosci Biotechnol Biochem 2008;72:1290–8.10.1271/bbb.70781Search in Google Scholar PubMed

22. Russell-Jones G, McTavish K, McEwan J, Rice J, Nowotnik D. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumors. J Inorg Biochem 2004;98:1625–33.10.1016/j.jinorgbio.2004.07.009Search in Google Scholar PubMed

23. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antiox Redox Signal 2009;11:3013–69.10.1089/ars.2009.2541Search in Google Scholar PubMed PubMed Central

24. Sznarkowska A, Kostecka A, Meller K, Bielawski KP. Inhibition of cancer antioxidant defense by natural compounds. Oncotarget 2017;8:15996–6016.10.18632/oncotarget.13723Search in Google Scholar PubMed PubMed Central

25. Stompor M. 6-Acetamidoflavone obtained by microbiological and chemical methods and its antioxidant activity. J Biotechnol 2016;237:25–34.10.1016/j.jbiotec.2016.09.006Search in Google Scholar PubMed

26. Stompor M, Świtalska M, Wietrzyk J. Synthesis and biological evaluation of acyl derivatives of hydroxyflavones as potent antiproliferative agents against drug resistance cell lines. Z Naturforsch C J Biosci 2018;73:87–93.10.1515/znc-2017-0093Search in Google Scholar PubMed

27. Lin CH, Chang CY, Lee KR, Lin HJ, Chen TH, Wan L. Flavones inhibit breast cancer proliferation through the Akt/FAXO3a signaling pathway. BMC Cancer 2015;15:958.10.1186/s12885-015-1965-7Search in Google Scholar PubMed PubMed Central

28. Moorkoth S. Synthesis and anti-cancer activity of novel thiazolidinone analogs of 6-aminoflavone. Chem Pharm Bull 2015;63:974–85.10.1248/cpb.c15-00454Search in Google Scholar PubMed

29. Inoue J, Ikeda S, Kanayama T, Sato R. The flavonoid derivative 4′-nitro-6-hydroxyflavone suppresses the activity of HNF4α and stimulates the degradation of the HNFα protein through the activation of AMPK. Biosci Biotechnol Biochem 2017;81:1548–52.10.1080/09168451.2017.1325316Search in Google Scholar PubMed

30. Dίaz J, Martinez DC, Lόpez LV, Mendez GM, Vera R, Loaiza AE. Synthesis and in vitro antiproliferative activity of flavone and 6-hydroxyflavone oxime ethers derivatives. J Braz Chem Soc 2018;29:1–8.10.21577/0103-5053.20170128Search in Google Scholar

31. Luzzani GA, Callero MA, Kuruppu AI, Trapani V, Flumian C, Todaro L, et al. In vitro antitumor effect of AHR ligands aminoflavone (AFP 464) and benzothiazole (5F 203) in human renal carcinoma cells. J Cell Biochem 2017;118:4526–35.10.1002/jcb.26114Search in Google Scholar PubMed

32. Callero MA, Rodriguez CE, Sόlimo A, Bal de Kier Joffé E, Loaiza Perez AI. The immune system as a new possible cell target for AFP 464 in a spontaneous mammary cancer mouse model. J Cell Biochem 2017;118:2841–9.10.1002/jcb.25934Search in Google Scholar PubMed

33. Brinkman AM, Wu J, Ersland K, Xu W. Estrogen receptor α and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells. BMC Cancer 2014;14:344.10.1186/1471-2407-14-344Search in Google Scholar PubMed PubMed Central

34. Reinicke KE, Kuffel MJ, Goetz MP, Ames MM. Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells. Cancer Chemother Pharmacol 2010;66:575–8.10.1007/s00280-009-1198-zSearch in Google Scholar PubMed PubMed Central

35. Lv L, Liu C, Chen C, Yu X, Chen G, Shi Y, et al. Quercetin and doxorubicin co-encapsulated biotin receptor targeting nanoparticles for minimizing drug resistance in breast cancer. Oncotarget 2016;7:32184–99.10.18632/oncotarget.8607Search in Google Scholar PubMed PubMed Central

36. Cheng M, Zhu W, Li Q, Dai D, Hou Y. Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer. Oncotarget 2017;8:59068–85.10.18632/oncotarget.19146Search in Google Scholar PubMed PubMed Central

37. Kanso H, Inguimbert N, Istamboulie G, Barthelmebs L, Calas-Blanchard C, Noguer T. Chemiluminescence immunoassays for estradiol and ethinylestradiol based on new biotinylated estrogen derivatives. Anal Biochem 2017;537:63–8.10.1016/j.ab.2017.08.023Search in Google Scholar PubMed

38. Yang W, Cheng Y, Xu T, Wang X, Wen LP. Targeting cancer cells with biotin-dendrimer conjugates. Eur J Med Chem 2009;44:862–8.10.1016/j.ejmech.2008.04.021Search in Google Scholar PubMed

39. Liu Y, Wu X, Sun X, Wang D, Zhong Y, Jiang D, et al. Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding. Int J Nanomed 2017;12:5039–52.10.2147/IJN.S131878Search in Google Scholar PubMed PubMed Central

40. Hu J, Wu TM, Li HZ, Zuo ZP, Zhao YL, Yang L. The synthesis, structure-toxicity relationship of cisplatin derivatives for the mechanism research of cisplatin-induced nephrotoxicity. Bioorg Med Chem 2017;27:3591–4.10.1016/j.bmcl.2017.04.077Search in Google Scholar PubMed

41. Sakihama Y, Shimai T, Sakasai M, Ito T, Fukushi Y, Hashidoko Y, et al. A photoaffinity probe designed for host-specific signal flavonoid receptors in phytopathogenic Peronosporomycete zoospores of Aphanomyces cochlioides. Archiv Biochem Biophys 2004;432:145–51.10.1016/j.abb.2004.09.017Search in Google Scholar PubMed

42. Li K, Qiu L, Lv G, Zhao X, Wang S, Lin J. Conjugate of biotin with silicon (IV) phthalocyanine for tumor-targeting photodynamic therapy. J Photochem Photobiol B 2017;174:243–50.10.1016/j.jphotobiol.2017.08.003Search in Google Scholar PubMed

43. Wang RE, Hunt CR, Chen JW, Taylor JS. Biotinylated quercetin as an intrinsic photoaffinity proteomics probe for the identification of quercetin target proteins. Bioorg Med Chem 2011;19:4710–20.10.1016/j.bmc.2011.07.005Search in Google Scholar PubMed PubMed Central

44. You L, Zhu H, Wang C, Wang F, Li Y, Li Y, et al. Scutellarin inhibits HeLa cell growth and glycolysis by inhibiting the activity of pyruvate kinase M2. Bioorg Med Chem 2017;27:5404–8.10.1016/j.bmcl.2017.11.011Search in Google Scholar PubMed

45. Soural M, Hodon J, Dickinson NJ, Sidova V, Gurska S, Dzubak P, et al. Preparation of conjugates of cytotoxic lupane triterpens with biotin. Bioconj Chem 2015;26:2563–70.10.1021/acs.bioconjchem.5b00567Search in Google Scholar PubMed

46. Sidoryk K, Jaromin A, Edward JA, Świtalska M, Stefańska J, Cmoch P, et al. Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities. Eur J Med Chem 2014;78:304–13.10.1016/j.ejmech.2014.03.060Search in Google Scholar PubMed

Received: 2018-11-29
Revised: 2019-03-21
Accepted: 2019-04-16
Published Online: 2019-05-17
Published in Print: 2019-07-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 9.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2018-0195/html?lang=en
Scroll to top button